The Antisoma Board
Michael Pappas, LLB, CA Non-Executive Chairman
Michael was appointed Non-Executive Director of Antisoma Research Ltd in 1993 and of Antisoma plc on formation of the Company in October 1996. He subsequently became Non-executive Chairman in December 2011. Michael has a degree in law and is a member of the Institute of Chartered Accountants of Scotland. Michael is CEO of Alpheus Capital Management Ltd a private equity advisory firm and holds various non-executive director positions including Kudos Independent Financial Services Ltd.
Mike Bretherton, BA, ACA, Finance Director
Mike was appointed as a Non-Executive Director of the Company in March 2011 and subsequently took on the role of Finance Director on admission to AIM in January 2012. He is also a Director of ORA Capital Partners Limited, an investment company operating principally in the technology, resources and financial services sectors. In addition, Mike is a Non-executive director of Tissue Regenix Group plc, Nanoco Group plc, Obtala Resources Limited, Oxford Advanced Surfaces Group Plc and Oxford Pharmascience Group plc, all of which are AIM listed. He has a degree in Economics from Leeds University and is a member of the Institute of Chartered Accountants in England and Wales. His early career included working as an accountant and manager with PriceWaterhouse for 7 years in London and the Middle East, followed by finance roles at the Plessey Company plc, Bridgend Group plc, Mapeley Limited and Lionhead Studios Limited.
Dale Boden, BA Non-Executive Director
Dale was appointed Non-Executive Director in September 2005. He is President of BF Capital Inc., a US private investment firm that focuses on private equity, venture capital investing and real estate development. He also serves on the boards of several US companies. Dale is based in Louisville, Kentucky and was a Director and member of the executive committee of Aptamera, Inc. prior to its acquisition by Antisoma.
Ross Hollyman, Non-Executive Director
Ross was appointed Non-Executive Director in December 2011. He has been employed in the investment industry in the UK for over 17 years. He has previously been an investment director at GAM Limited and JP Morgan Fleming Asset Management and most recently was Head of Global Equities at Liontrust Asset Management plc.
Page last updated: 4 January 2012